Pre-aggregated Aβ25-35 alters arginine metabolism in the rat hippocampus and prefrontal cortex

Neuroscience

Volumn 193, Issue , 2011, Pages 269-282

  Liu, Ping ^a   Jing, Yu ^a   Collie, Nicola D ^a   Campbell, Saskia A ^a   Zhang, Hu ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Agmatine; Amyloid beta; Arginine; Hippocampus; Nitric oxide synthase; Polyamines

Indexed keywords

AMYLOID BETA PROTEIN[25-35]; ARGINASE; ARGININE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; DENTATE GYRUS; ENZYME ACTIVITY; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; HIPPOCAMPUS; MALE; NEUROCHEMISTRY; NONHUMAN; OPEN FIELD TEST; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN METABOLISM; RAT;

AMINO ACIDS; AMYLOID BETA-PEPTIDES; ANIMALS; ARGININE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, LIQUID; CLUSTER ANALYSIS; EXPLORATORY BEHAVIOR; HIPPOCAMPUS; MALE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; PEPTIDE FRAGMENTS; PREFRONTAL CORTEX; RATS; TANDEM MASS SPECTROMETRY;

EID: 80052448797     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.07.054     Document Type: Article

References (115)

1. Abe K., Abe Y., Saito H. Agmatine suppresses nitric oxide production in microglia. Brain Res 2000, 872:141-148.
2. Alkam T., Nitta A., Mizoguchi H., Saito K., Seshima M., Itoh A., Yamada K., Nabeshima T. Restraining tumor necrosis factor-alpha by thalidomide prevents the amyloid beta-induced impairment of recognition memory in mice. Behav Brain Res 2008, 189:100-106.
3. Amaral D.G., Witter M.P. Hippocampal formation. The rat nervous system 1995, 443-493. Academic Press, San Diego, CA. 2nd ed. G. Paxinos (Ed.).
4. Arndt M.A., Battaglia V., Parisi E., Lortie M.J., Isome M., Baskerville C., Pizzo D.P., Ientile R., Colombatto S., Toninello A., Satriano J. The arginine metabolite agmatine protects mitochondrial function and confers resistance to cellular apoptosis. Am J Physiol Cell Physiol 2009, 296:C1411-C1419.
5. Bergin D.H., Liu P. Agmatine protects against beta-amyloid25-35-induced memory impairments in the rat. Neuroscience 2010, 169:794-811.
6. Bisel B.E., Henkins K.M., Parfitt K.D. Alzheimer amyloid beta-peptide A-beta25-35 blocks adenylate cyclase-mediated forms of hippocampal long-term potentiation. Ann N Y Acad Sci 2007, 1097:58-63.
7. Blanchard B.J., Konopka G., Russell M., Ingram V.M. Mechanism and prevention of neurotoxicity caused by beta-amyloid peptides: relation to Alzheimer's disease. Brain Res 1997, 776:40-50.
8. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
9. Braissant O., Gotoh T., Loup M., Mori M., Bachmann C. l-arginine uptake, the citrulline-NO cycle and arginase II in the rat brain: an in situ hybridization study. Brain Res Mol Brain Res 1999, 70:231-241.
10. Bredt D.S., Snyder S.H. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci U S A 1990, 87:682-685.
11. Cheng G., Whitehead S.N., Hachinski V., Cechetto D.F. Effects of pyrrolidine dithiocarbamate on beta-amyloid (25-35)-induced inflammatory responses and memory deficits in the rat. Neurobiol Dis 2006, 23:140-151.
12. Chisari M., Merlo S., Sortino M.A., Salomone S. Long-term incubation with beta-amyloid peptides impairs endothelium-dependent vasodilatation in isolated rat basilar artery. Pharmacol Res 2010, 61:157-161.
13. Cho D.H., Nakamura T., Fang J., Cieplak P., Godzik A., Gu Z., Lipton S.A. S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury. Science 2009, 324:102-105.
14. Christian E.P., Dudek F.E. Characteristics of local excitatory circuits studied with glutamate microapplication in the CA3 area of rat hippocampal slices. J Neurophysiol 1988, 59:90-109.
15. Colton C.A., Mott R.T., Sharpe H., Xu Q., Van Nostrand W.E., Vitek M.P. Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD. J Neuroinflammation 2006, 3:27.
16. D'Aquila P.S., Peana A.T., Carboni V., Serra G. Exploratory behaviour and grooming after repeated restraint and chronic mild stress: effect of desipramine. Eur J Pharmacol 2000, 399:43-47.
17. de la Torre J.C. Cerebrovascular and cardiovascular pathology in Alzheimer's disease. Int Rev Neurobiol 2009, 84:35-48.
18. Delobette S., Privat A., Maurice T. In vitro aggregation facilities beta-amyloid peptide-(25-35)-induced amnesia in the rat. Eur J Pharmacol 1997, 319:1-4.
19. Dickson D.W., Lee S.C., Mattiace L.A., Yen S.H., Brosnan C. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 1993, 7:75-83.
20. Durante W., Johnson F.K., Johnson R.A. Arginase: a critical regulator of nitric oxide synthesis and vascular function. Clin Exp Pharmacol Physiol 2007, 34:906-911.
21. El Khoury J., Hickman S.E., Thomas C.A., Cao L., Silverstein S.C., Loike J.D. Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils. Nature 1996, 382:716-719.
22. Feng Y., LeBlanc M.H. Effect of agmatine on the time course of brain inflammatory cytokines after injury in rat pups. Ann N Y Acad Sci 2003, 1009:152-156.
23. Gruden M.A., Davudova T.B., Malisauskas M., Zamotin V.V., Sewell R.D., Voskresenskaya N.I., Kostanyan I.A., Sherstnev V.V., Morozova-Roche L.A. Autoimmune responses to amyloid structures of Abeta(25-35) peptide and human lysozyme in the serum of patients with progressive Alzheimer's disease. Dement Geriatr Cogn Disord 2004, 18:165-171.
24. Gulyaeva N.V., Stepanichev M.Y. Abeta(25-35) as proxyholder for amyloidogenic peptides: in vivo evidence. Exp Neurol 2010, 222:6-9.
25. Gupta N., Zhang H., Liu P. Behavioral and neurochemical effects of acute putrescine depletion by difluoromethylornithine in rats. Neuroscience 2009, 161:691-706.
26. Halaris A., Plietz J. Agmatine: metabolic pathway and spectrum of activity in brain. CNS Drugs 2007, 21:885-900.
27. Hansmannel F., Sillaire A., Kamboh M.I., Lendon C., Pasquier F., Hannequin D., Laumet G., Mounier A., Ayral A.M., DeKosky S.T., Hauw J.J., Berr C., Mann D., Amouyel P., Campion D., Lambert J.C. Is the urea cycle involved in Alzheimer's disease?. J Alzheimers Dis 2010, 21:1013-1021.
28. Hardy J.A., Higgins G.A. Alzheimer's disease: the amyloid cascade hypothesis. Science 1992, 256:184-185.
29. Harkany T., Abrahám I., Timmerman W., Laskay G., Tóth B., Sasvári M., Kónya C., Sebens J.B., Korf J., Nyakas C., Zarándi M., Soós K., Penke B., Luiten P.G. Beta-amyloid neurotoxicity is mediated by a glutamate-triggered excitotoxic cascade in rat nucleus basalis. Eur J Neurosci 2000, 12:2735-2745.
30. Harris J.A., Devidze N., Verret L., Ho K., Halabisky B., Thwin M.T., Kim D., Hamto P., Lo I., Yu G.Q., Palop J.J., Masliah E., Mucke L. Transsynaptic progression of amyloid-β-induced neuronal dysfunction within the entorhinal-hippocampal network. Neuron 2010, 68:428-441.
31. Homberg J.R., van den Akker M., Raasø H.S., Wardeh G., Binnekade R., Schoffelmeer A.N., de Vries T.J. Enhanced motivation to self-administer cocaine is predicted by self-grooming behaviour and relates to dopamine release in the rat medial prefrontal cortex and amygdala. Eur J Neurosci 2002, 15:1542-1550.
32. Hong S., Kim C.Y., Lee J.E., Seong G.J. Agmatine protects cultured retinal ganglion cells from tumor necrosis factor-alpha-induced apoptosis. Life Sci 2009, 84:28-32.
33. Hyman B.T., Damasio H., Damasio A.R., Van Hoesen G.W. Alzheimer's disease. Annu Rev Public Health 1989, 10:115-140.
34. Jeynes B., Provias J. Significant negative correlations between capillary expressed eNOS and Alzheimer lesion burden. Neurosci Lett 2009, 463:244-248.
35. Kaminsky Y.G., Marlatt M.W., Smith M.A., Kosenko E.A. Subcellular and metabolic examination of amyloid-beta peptides in Alzheimer disease pathogenesis: evidence for Abeta(25-35). Exp Neurol 2010, 221:26-37.
36. Keser A., Balkan B., Gozen O., Kanit L., Pogun S. Hippocampal neuronal nitric oxide synthase (nNOS) is regulated by nicotine and stress in female but not in male rats. Brain Res 2011, 1368:134-142.
37. Kesner R.P., Lee I., Gilbert P. A behavioral assessment of hippocampal function based on a subregional analysis. Rev Neurosci 2004, 15:333-351.
38. Khovryakov A.V., Podrezova E.P., Kruglyakov P.P., Shikhanov N.P., Balykova M.N., Semibratova N.V., Sosunov A.A., McKhann G., Airapetyants M.G. Involvement of the NO synthase system in stress-mediated brain reactions. Neurosci Behav Physiol 2010, 40:333-337.
39. Klementiev B., Novikova T., Novitskaya V., Walmod P.S., Dmytriyeva O., Pakkenberg B., Berezin V., Bock E. A neural cell adhesion molecule-derived peptide reduces neuropathological signs and cognitive impairment induced by Abeta25-35. Neuroscience 2007, 145:209-224.
40. Kubo T., Nishimura S., Kumagae Y., Kaneko I. In vivo conversion of racemized beta-amyloid ([d-Ser 26]A beta 1-40) to truncated and toxic fragments ([d-Ser 26]A beta 25-35/40) and fragment presence in the brains of Alzheimer's patients. J Neurosci Res 2002, 70:474-483.
41. Law A., Gauthier S., Quirion R. Say NO to Alzheimer's disease: the putative links between nitric oxide and dementia of the Alzheimer's type. Brain Res Brain Res Rev 2001, 35:73-96.
42. Leitch B., Shevtsova O., Reusch K., Bergin D.H., Liu P. Spatial learning-induced increase in agmatine levels at hippocampal CA1 synapses. Synapse 2011, 65:146-153.
43. Li G., Regunathan S., Barrow C.J., Eshraghi J., Cooper R., Reis D.J. Agmatine: an endogenous clonidine-displacing substance in the brain. Science 1994, 263:966-969.
44. Li L., Xu B., Zhu Y., Chen L., Sokabe M., Chen L. DHEA prevents Abeta(25-35)-impaired survival of newborn neurons in the dentate gyrus through a modulation of PI3K-Akt-mTOR signaling. Neuropharmacology 2010, 59:323-333.
45. Li X., Zuo P. Effects of Abeta25-35 on neurogenesis in the adult mouse subventricular zone and dentate gyrus. Neurol Res 2005, 27:218-222.
46. Lim H.K., Lim H.K., Ryoo S., Benjo A., Shuleri K., Miriel V., Baraban E., Camara A., Soucy K., Nyhan D., Shoukas A., Berkowitz D.E. Mitochondrial arginase II constrains endothelial NOS-3 activity. Am J Physiol Heart Circ Physiol 2007, 293:H3317-H3324.
47. Limón I.D., Díaz A., Mendieta L., Chamorro G., Espinosa B., Zenteno E., Guevara J. Amyloid-beta(25-35) impairs memory and increases NO in the temporal cortex of rats. Neurosci Res 2009, 63:129-137.
48. Limón I.D., Mendieta L., Díaz A., Chamorro G., Espinosa B., Zenteno E., Guevara J. Neuroprotective effect of alpha-asarone on spatial memory and nitric oxide levels in rats injected with amyloid-beta((25-35)). Neurosci Lett 2009, 453:98-103.
49. Lisman J.E. Relating hippocampal circuitry to function: recall of memory sequences by reciprocal dentate-CA3 interactions. Neuron 1999, 22:233-242.
50. Liu P., Bergin D.H. Differential effects of intracerebroventricular microinfusion of agmatine on spatial working and reference memory in the rat. Neuroscience 2009, 159:951-961.
51. Liu P., Chary S., Devaraj R., Jing Y., Darlington C.L., Smith P.F., Tucker I.G., Zhang H. Effects of aging on agmatine levels in memory-associated brain structures. Hippocampus 2008, 18:853-856.
52. Liu P., Collie N.D. Behavioral effects of agmatine in naive rats are task- and delay-dependent. Neuroscience 2009, 163:82-96.
53. Liu P., Collie N.D., Chary S., Jing Y., Zhang H. Spatial learning results in elevated agmatine levels in the rat brain. Hippocampus 2008, 18:1094-1098.
54. Liu P., Gupta N., Jing Y., Zhang H. Age-related changes in polyamines in memory-associated brain structures in rats. Neuroscience 2008, 155:789-796.
55. Liu P., Jing Y., Collie N.D., Chary S., Zhang H. Memory-related changes in l-citrulline and agmatine in the rat brain. Hippocampus 2009, 19:597-602.
56. Liu P., Jing Y., Zhang H. Age-related changes in arginine and its metabolites in memory-associated brain structures. Neuroscience 2009, 164:611-628.
57. Liu P., Rushaidhi M., Collie N.D., Leong M.T., Zhang H. Behavioral effects of intracerebroventricular microinfusion of agmatine in adult rats. Behav Neurosci 2008, 122:557-569.
58. Liu P., Smith P.F., Appleton I., Darlington C.L., Bilkey D.K. Nitric oxide synthase and arginase in the rat hippocampus and the entorhinal, perirhinal, postrhinal and temporal cortices: regional variations and age-related changes. Hippocampus 2003, 13:859-867.
59. Liu P., Smith P.F., Appleton I., Darlington C.L., Bilkey D.K. Regional variations and age-related changes in nitric oxide synthase and arginase in the sub-regions of the hippocampus. Neuroscience 2003, 119:679-687.
60. Liu P., Smith P.F., Appleton I., Darlington C.L., Bilkey D.K. Age-related changes in nitric oxide synthase and arginase in the rat prefrontal cortex. Neurobiol Aging 2004, 25:547-552.
61. Liu P., Smith P.F., Appleton I., Darlington C.L., Bilkey D.K. Potential involvement of NOS and arginase in age-related behavioural impairments. Exp Gerontol 2004, 39:1207-1222.
62. Liu P., Smith P.F., Appleton I., Darlington C.L., Bilkey D.K. Hippocampal nitric oxide synthase and arginase and age-associated behavioural deficits. Hippocampus 2005, 15:642-655.
63. Liu P., Zhang H., Devaraj R., Ganesalingam G.S., Smith P.F. A multivariate analysis of the effects of aging on glutamate, GABA and arginine metabolites in the rat vestibular nucleus. Hear Res 2010, 269:122-133.
64. Malaterre J., Strambi C., Aouane A., Strambi A., Rougon G., Cayre M. A novel role for polyamines in adult neurogenesis in rodent brain. Eur J Neurosci 2004, 20:317-330.
65. Malinski T. Nitric oxide and nitroxidative stress in Alzheimer's disease. J Alzheimers Dis 2007, 11:207-218.
66. Maurice T., Lockhart B.P., Su T.P., Privat A. Reversion of beta 25-35-amyloid peptide-induced amnesia by NMDA receptor-associated glycine site agonists. Brain Res 1996, 731:249-253.
67. Moinard C., Cynober L., de Bandt J.P. Polyamines: metabolism and implications in human diseases. Clin Nutr 2005, 24:184-197.
68. Mondragón R., Mayagoitia L., López-Luján A., Díaz J.L. Social structure features in three inbred strains of mice, C57Bl/6J, Balb/cj, and NIH: a comparative study. Behav Neural Biol 1987, 47:384-391.
69. Morris S.M. Arginine: beyond protein. Am J Clin Nutr 2006, 83:508S-512S.
70. Morrison L.D., Becker L., Ang L.C., Kish S.J. Polyamines in human brain: regional distribution and influence of aging. J Neurochem 1995, 65:636-642.
71. Morrison L.D., Cao X.C., Kish S.J. Ornithine decarboxylase in human brain: influence of aging, regional distribution, and Alzheimer's disease. J Neurochem 1998, 71:288-294.
72. Morrison L.D., Kish S.J. Brain polyamine levels are altered in Alzheimer's disease. Neurosci Lett 1995, 197:5-8.
73. Nilsson T., Bogdanovic N., Volkman I., Winblad B., Folkesson R., Benedikz E. Altered subcellular localization of ornithine decarboxylase in Alzheimer's disease brain. Biochem Biophys Res Commun 2006, 344:640-646.
74. Olariu A., Tran M.H., Yamada K., Mizuno M., Hefco V., Nabeshima T. Memory deficits and increased emotionality induced by beta-amyloid (25-35) are correlated with the reduced acetylcholine release and altered phorbol dibutyrate binding in the hippocampus. J Neural Transm 2001, 108:1065-1079.
75. Oredsson S.M. Polyamine dependence of normal cell-cycle progression. Biochem Soc Trans 2003, 31:366-370.
76. Ozaki M., Gotoh T., Nagasaki A., Miyanaka K., Takeya M., Fujiyama S., Tomita K., Mori M. Expression of arginase II and related enzymes in the rat small intestine and kidney. J Biochem 1999, 125:586-593.
77. Palop J.J., Chin J., Roberson E.D., Wang J., Thwin M.T., Bien-Ly N., Yoo J., Ho K.O., Yu G.Q., Kreitzer A., Finkbeiner S., Noebels J.L., Mucke L. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease. Neuron 2007, 55:697-711.
78. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1998, Academic Press, San Diego, CA. 4th ed.
79. Provias J., Jeynes B. Neurofibrillary tangles and senile plaques in Alzheimer's brains are associated with reduced capillary expression of vascular endothelial growth factor and endothelial nitric oxide synthase. Curr Neurovasc Res 2008, 5:199-205.
80. Regunathan S., Feinstein D.L., Reis D.J. Anti-proliferative and anti-inflammatory actions of imidazoline agents. Are imidazoline receptors involved?. Ann N Y Acad Sci 1999, 881:410-419.
81. Reis D.J., Regunathan S. Is agmatine a novel neurotransmitter in brain?. Trends Pharmacol Sci 2000, 21:187-193.
82. Resende R., Pereira C., Agostinho P., Vieira A.P., Malva J.O., Oliveira C.R. Susceptibility of hippocampal neurons to Abeta peptide toxicity is associated with perturbation of Ca2+ homeostasis. Brain Res 2007, 1143:11-21.
83. Rock D.M., Macdonald R.L. Polyamine regulation of N-methyl-d-aspartate receptor channels. Annu Rev Pharmacol Toxicol 1995, 35:463-482.
84. Rushaidhi M, Zhang H, Liu P (2008) Agmatine suppresses age-related increases in nitric oxide synthase activity in the rat hippocampus and prefrontal cortex. In: Proceedings of the International Australasian Winter Conference on Brain Research, Vol. 26. 4.36.
85. Satriano J. Agmatine: at the crossroads of the arginine pathways. Ann N Y Acad Sci 2003, 1009:34-43.
86. Selkoe D.J. Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein. J Alzheimers Dis 2001, 3:75-81.
87. Spruijt B.M., van Hooff J.A., Gispen W.H. Ethology and neurobiology of grooming behavior. Physiol Rev 1992, 72:825-852.
88. Stepanichev M.Y., Moiseeva Y.V., Lazareva N.A., Gulyaeva N.V. Studies of the effects of fragment (25-35) of beta-amyloid peptide on the behavior of rats in a radial maze. Neurosci Behav Physiol 2005, 35:511-518.
89. Stepanichev M.Y., Moiseeva Y.V., Lazareva N.A., Onufriev M.V., Gulyaeva N.V. Single intracerebroventricular administration of amyloid-beta (25-35) peptide induces impairment in short-term rather than long-term memory in rats. Brain Res Bull 2003, 61:197-205.
90. Stepanichev M.Y., Zdobnova I.M., Zarubenko I.I., Lazareva N.A., Gulyaeva N.V. Studies of the effects of central administration of beta-amyloid peptide (25-35): pathomorphological changes in the hippocampus and impairment of spatial memory. Neurosci Behav Physiol 2006, 36:101-106.
91. Stepanichev M.Y., Zdobnova I.M., Zarubenko I.I., Moiseeva Y.V., Lazareva N.A., Onufriev M.V., Gulyaeva N.V. Amyloid-beta(25-35)-induced memory impairments correlate with cell loss in rat hippocampus. Physiol Behav 2004, 80:647-655.
92. Sun M.K., Alkon D.L. Impairment of hippocampal CA1 heterosynaptic transformation and spatial memory by beta-amyloid(25-35). J Neurophysiol 2002, 87:2441-2449.
93. Tran M.H., Yamada K., Olariu A., Mizuno M., Ren X.H., Nabeshima T. Amyloid beta-peptide induces nitric oxide production in rat hippocampus: association with cholinergic dysfunction and amelioration by inducible nitric oxide synthase inhibitors. FASEB J 2001, 15:1407-1409.
94. van Erp A.M., Kruk M.R., Meelis W., Willekens-Bramer D.C. Effect of environmental stressors on time course, variability and form of self-grooming in the rat: handling, social contact, defeat, novelty, restraint and fur moistening. Behav Brain Res 1994, 65:47-55.
95. Van Hoesen G.W., Augustinack J.C., Dierking J., Redman S.J., Thangavel R. The parahippocampal gyrus in Alzheimer's disease. Clinical and preclinical neuroanatomical correlates. Ann N Y Acad Sci 2000, 911:254-274.
96. Vane J.R., Mitchell J.A., Appleton I., Tomlinson A., Bishop-Bailey D., Croxtall J., Willoughby D.A. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc Natl Acad Sci U S A 1994, 91:2046-2050.
97. Varadarajan S., Kanski J., Aksenova M., Lauderback C., Butterfield D.A. Different mechanisms of oxidative stress and neurotoxicity for Alzheimer's A beta(1-42) and A beta(25-35). J Am Chem Soc 2001, 123:5625-5631.
98. Varadarajan S., Yatin S., Aksenova M., Butterfield D.A. Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity. J Struct Biol 2000, 130:184-208.
99. Wallace H.M. The physiological role of the polyamines. Eur J Clin Invest 2000, 30:1-3.
100. Wallace H.M., Fraser A.V., Hughes A. A perspective of polyamine metabolism. Biochem J 2003, 376:1-14.
101. Wiesinger H. Arginine metabolism and the synthesis of nitric oxide in the nervous system. Prog Neurobiol 2001, 64:365-391.
102. Williams K. Interactions of polyamines with ion channels. Biochem J 1997, 325:289-297.
103. Williams K., Zappia A.M., Pritchett D.B., Shen Y.M., Molinoff P.B. Sensitivity of the N-methyl-d-aspartate receptor to polyamines is controlled by NR2 subunits. Mol Pharmacol 1994, 45:803-809.
104. Wu G., Morris S.M. Arginine metabolism: nitric oxide and beyond. Biochem J 1998, 336:1-17.
105. Wu G.M., Hou X.Y. Oligomerized Abeta25-35 induces increased tyrosine phosphorylation of NMDA receptor subunit 2A in rat hippocampal CA1 subfield. Brain Res 2010, 1343:186-193.
106. Yamaguchi Y., Kawashima S. Effects of amyloid-beta-(25-35) on passive avoidance, radial-arm maze learning and choline acetyltransferase activity in the rat. Eur J Pharmacol 2001, 412:265-272.
107. Yatin S.M., Yatin M., Aulick T., Ain K.B., Butterfield D.A. Alzheimer's amyloid β-peptide associated free radicals increase rat embryonic neuronal polyamine uptake and ornithine decarboxylase activity: protective effect of vitamin E. Neurosci Lett 1999, 263:17-20.
108. Yatin S.M., Yatin M., Varadarajan S., Ain K.B., Butterfield D.A. Role of spermine in amyloid beta-peptide-associated free radical-induced neurotoxicity. J Neurosci Res 2001, 63:395-401.
109. Yenkoyan K., Safaryan K., Navasardyan G., Mkrtchyan L., Aghajanov M. Effects of beta-amyloid on behavioral and amino acids spectrum in rats' brain and their modulation by embryonic proteins. Neurochem Int 2009, 54:292-298.
110. Yi J., Horky L.L., Friedlich A.L., Shi Y., Rogers J.T., Huang X. l-arginine and Alzheimer's disease. Int J Clin Exp Pathol 2009, 2:211-238.
111. Yin K.J., Lee J.M., Chen H., Xu J., Hsu C.Y. Abeta25-35 alters Akt activity, resulting in Bad translocation and mitochondrial dysfunction in cerebrovascular endothelial cells. J Cereb Blood Flow Metab 2005, 25:1445-1455.
112. Yu H., Iyer R.K., Kern R.M., Rodriguez W.I., Grody W.W., Cederbaum S.D. Expression of arginase isozymes in mouse brain. J Neurosci Res 2001, 66:406-422.
113. Zhang J., Snyder S.H. Nitric oxide in the nervous system. Annu Rev Pharmacol Toxicol 1995, 35:213-233.
114. Zhu M.Y., Wang W.P., Huang J., Feng Y.Z., Regunathan S., Bissette G. Repeated immobilization stress alters rat hippocampal and prefrontal cortical morphology in parallel with endogenous agmatine and arginine decarboxylase levels. Neurochem Int 2008, 53:346-354.
115. Zolman J.F. Biostatistics: experimental design and statistical inference 1993, Oxford University Press, Oxford.